![Jonathan Rothbard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Rothbard
Directeur Général chez
Katexco Pharmaceuticals Corp.
Profil
Jonathan B. Rothbard was the founder of Amylin Pharmaceuticals, Inc. (1989), ImmuLogic Pharmaceutical Corp.
(1989), Cellgate, Inc. (1998), and Katexco Pharmaceuticals Corp.
(2018) with titles including Chief Scientific Officer-Palo Alto at ImmuLogic Pharmaceutical Corp.
and Chief Scientific Officer at Cellgate, Inc., and Chief Executive Officer, Director & CSO at Katexco Pharmaceuticals Corp.
Dr. Rothbard is also the founder of ETHZilla Corp.
Dr. Rothbard is currently the Director, Chief Executive & Scientific Officer at CannBioRex Pharmaceuticals Corp.
Former positions include Head-Molecular Immunology Laboratory at Imperial Cancer Research Fund Trading Ltd. and Chief Scientific Officer at KBL Merger Corp.
IV.
Education includes a doctorate from The Trustees of Columbia University in The City of New York (1977) and an undergraduate degree from Hamilton College (New York) (1973).
Postes actifs de Jonathan Rothbard
| Sociétés | Poste | Début |
|---|---|---|
Katexco Pharmaceuticals Corp.
 Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as medical marijuana company which develops drugs for treatment of rheumatoid arthritis and inflammatory bowel disease | Directeur Général | 01/11/2018 |
CannBioRex Pharmaceuticals Corp.
 CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel synthetic pharmaceutical products | Directeur Général | - |
Anciens postes connus de Jonathan Rothbard
| Sociétés | Poste | Fin |
|---|---|---|
| FORUM MARKETS, INCORPORATED | Fondateur | 07/05/2024 |
Cellgate, Inc.
 Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals products | Fondateur | 01/01/2004 |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Fondateur | 01/01/1995 |
Imperial Cancer Research Fund Trading Ltd.
 Imperial Cancer Research Fund Trading Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Fondateur | - |
Formation de Jonathan Rothbard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellgate, Inc.
Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals products | Health Technology |
Imperial Cancer Research Fund Trading Ltd.
Imperial Cancer Research Fund Trading Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KBL Merger Corp. IV
 KBL Merger Corp. IV Financial ConglomeratesFinance Operates as blank check company | Finance |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel synthetic pharmaceutical products | Health Technology |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as medical marijuana company which develops drugs for treatment of rheumatoid arthritis and inflammatory bowel disease | Health Technology |
180 Life Sciences Corp.
 180 Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for chronic pain and inflammatory diseases | Health Technology |
